Feasibility of Mini-tablets As a Flexible Drug Delivery Tool
Overview
Authors
Affiliations
Mini-tablets have potential applications as a flexible drug delivery tool in addition to their generally perceived use as multi-particulates. That is, mini-tablets could provide flexibility in dose finding studies and/or allow for combination therapies in the clinic. Moreover, mini-tablets with well controlled quality attributes could be a prudent choice for administering solid dosage forms as a single unit or composite of multiple mini-tablets in patient populations with swallowing difficulties (e.g., pediatric and geriatric populations). This work demonstrated drug substance particle size and concentration ranges that achieve acceptable mini-tablet quality attributes for use as a single or composite dosage unit. Immediate release and orally disintegrating mini-tablet formulations with 30μm to 350μm (particle size d) acetaminophen and Compap™ L (90% acetaminophen) at concentrations equivalent to 6.7% and 26.7% acetaminophen were evaluated. Mini-tablets achieved acceptable weight variability, tensile strength, friability, and disintegration time at a reasonable solid fraction for each formulation. The content uniformity was acceptable for mini-tablets of 6.7% formulations with ≤170μm drug substance, mini-tablets of all 26.7% formulations, and composite dosage units containing five or more mini-tablets of any formulation. Results supported the manufacturing feasibility of quality mini-tablets, and their applicability as a flexible drug delivery tool.
Manufacturing pharmaceutical mini-tablets for pediatric patients using drop-on-demand printing.
Sundarkumar V, Wang W, Nagy Z, Reklaitis G Int J Pharm. 2023; 644:123355.
PMID: 37647980 PMC: 10808949. DOI: 10.1016/j.ijpharm.2023.123355.
Alalaiwe A, Alsenaidy M, Almalki Z, Fayed M Pharmaceutics. 2023; 15(3).
PMID: 36986784 PMC: 10056513. DOI: 10.3390/pharmaceutics15030923.
Dose Titration of Solid Dosage Forms via FDM 3D-Printed Mini-Tablets.
Gorkem Buyukgoz G, Kossor C, Ji S, Guvendiren M, Dave R Pharmaceutics. 2022; 14(11).
PMID: 36365124 PMC: 9695869. DOI: 10.3390/pharmaceutics14112305.
Woerdenbag H, Visser J, Leferink Op Reinink M, van Orsoy R, Eissens A, Hagedoorn P Pharmaceutics. 2022; 14(2).
PMID: 35214052 PMC: 8878961. DOI: 10.3390/pharmaceutics14020320.
Hejduk A, Tezyk M, Jakubowska E, Kruger K, Lulek J AAPS PharmSciTech. 2022; 23(1):60.
PMID: 35059900 PMC: 8816488. DOI: 10.1208/s12249-021-02185-6.